Target Name: Interferon-gamma Receptor
NCBI ID: P16514
Review Report on Interferon-gamma Receptor Target / Biomarker Content of Review Report on Interferon-gamma Receptor Target / Biomarker
Interferon-gamma Receptor
Other Name(s): None

IGR: A Protein Involved in The Immune Response

The interferon-gamma receptor (IGR) is a protein that plays a crucial role in the immune system. It is a type of receptor that is found on the surface of many different types of cells in the body, including immune cells, neurons, and muscles. The IGR is involved in the signaling process that helps the immune system to identify and destroy foreign substances like viruses and bacteria that may be causing illness.

One of the things that makes the IGR so important is its ability to activate an immune response. When the body encounters something that it recognizes as a foreign substance, the IGR sends a signal to the immune system to begin an attack. The IGR is able to do this because it is able to recognize and respond to specific molecules that are present in the environment.

One of the ways that the IGR is able to do this is by using a type of protein called a transcription factor. Transcription factors are proteins that are responsible for turning on the production of other proteins. The IGR uses transcription factors to help it to recognize specific molecules in the environment.

Another way that the IGR is involved in the immune response is by using a type of protein called an enzyme. Enzymes are proteins that are responsible for breaking down or breaking up other proteins. The IGR uses enzymes to help it to recognize and destroy foreign substances that may be causing illness.

The IGR is also involved in the regulation of inflammation. When the body is exposed to something that it recognizes as a foreign substance, the IGR helps to regulate the immune response and prevent excessive inflammation from occurring. This is important because excessive inflammation can cause a wide range of problems, including pain, swelling, and damage to tissues.

In addition to its role in the immune system, the IGR is also thought to have a number of potential drug-related targets. For example, some researchers are interested in using the IGR as a potential drug target because it is involved in the signaling process that helps the immune system to identify and destroy foreign substances. This means that targeting the IGR with drugs could potentially be an effective way to treat a wide range of diseases.

Another potential drug target for the IGR is its role in the regulation of inflammation. Many diseases, including rheumatoid arthritis, inflammatory bowel disease, and asthma, are characterized by inflammation. By targeting the IGR with drugs, researchers hope to be able to reduce the amount of inflammation in these diseases and potentially treat them.

Overall, the IGR is a protein that is involved in many important processes in the body. It is a potential drug target because it is involved in the signaling process that helps the immune system to identify and destroy foreign substances, and it is also involved in the regulation of inflammation. Further research is needed to fully understand the role of the IGR in the immune system and to identify potential drug targets.

Protein Name: Interferon-gamma Receptor

The "Interferon-gamma Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interferon-gamma Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK | IQCM | IQCN | IQGAP1 | IQGAP2 | IQGAP3 | IQSEC1 | IQSEC2 | IQSEC3 | IQSEC3P3 | IQUB | IRAG1 | IRAG1-AS1 | IRAG2 | IRAK1 | IRAK1BP1 | IRAK2 | IRAK3 | IRAK4 | IREB2 | IRF1 | IRF1-AS1 | IRF2 | IRF2BP1 | IRF2BP2 | IRF2BPL | IRF3 | IRF4